Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma

María-Victoria Mateos, Meletios A. Dimopoulos, Michele Cavo, Kenshi Suzuki, Andrzej Jakubowiak, Stefan Knop, Chantal Doyen, Paulo Lucio, Zsolt Nagy, Polina Kaplan, Ludek Pour, Mark Cook, Sebastian Grosicki, Andre Crepaldi, Anna M. Liberati, Philip Campbell, Tatiana Shelekhova, Sung-Soo Yoon, Genadi Iosava, Tomoaki Fujisaki & 9 others Mamta Garg, Christopher Chiu, Jianping Wang, Robin Carson, Wendy Crist, William Deraedt, Huong Nguyen, Ming Qi, Jesus San-Miguel

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)518-528
Number of pages11
JournalNew England Journal of Medicine
Volume378
Issue number6
DOIs
Publication statusPublished - Dec 12 2017
Externally publishedYes

Cite this

Mateos, M-V., Dimopoulos, M. A., Cavo, M., Suzuki, K., Jakubowiak, A., Knop, S., ... San-Miguel, J. (2017). Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. New England Journal of Medicine, 378(6), 518-528. https://doi.org/10.1056/NEJMoa1714678

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. / Mateos, María-Victoria; Dimopoulos, Meletios A.; Cavo, Michele; Suzuki, Kenshi; Jakubowiak, Andrzej; Knop, Stefan; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Kaplan, Polina; Pour, Ludek; Cook, Mark; Grosicki, Sebastian; Crepaldi, Andre; Liberati, Anna M.; Campbell, Philip; Shelekhova, Tatiana; Yoon, Sung-Soo; Iosava, Genadi; Fujisaki, Tomoaki; Garg, Mamta; Chiu, Christopher; Wang, Jianping; Carson, Robin; Crist, Wendy; Deraedt, William; Nguyen, Huong; Qi, Ming; San-Miguel, Jesus.

In: New England Journal of Medicine, Vol. 378, No. 6, 12.12.2017, p. 518-528.

Research output: Contribution to journalArticle

Mateos, M-V, Dimopoulos, MA, Cavo, M, Suzuki, K, Jakubowiak, A, Knop, S, Doyen, C, Lucio, P, Nagy, Z, Kaplan, P, Pour, L, Cook, M, Grosicki, S, Crepaldi, A, Liberati, AM, Campbell, P, Shelekhova, T, Yoon, S-S, Iosava, G, Fujisaki, T, Garg, M, Chiu, C, Wang, J, Carson, R, Crist, W, Deraedt, W, Nguyen, H, Qi, M & San-Miguel, J 2017, 'Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma', New England Journal of Medicine, vol. 378, no. 6, pp. 518-528. https://doi.org/10.1056/NEJMoa1714678
Mateos M-V, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S et al. Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. New England Journal of Medicine. 2017 Dec 12;378(6):518-528. https://doi.org/10.1056/NEJMoa1714678
Mateos, María-Victoria ; Dimopoulos, Meletios A. ; Cavo, Michele ; Suzuki, Kenshi ; Jakubowiak, Andrzej ; Knop, Stefan ; Doyen, Chantal ; Lucio, Paulo ; Nagy, Zsolt ; Kaplan, Polina ; Pour, Ludek ; Cook, Mark ; Grosicki, Sebastian ; Crepaldi, Andre ; Liberati, Anna M. ; Campbell, Philip ; Shelekhova, Tatiana ; Yoon, Sung-Soo ; Iosava, Genadi ; Fujisaki, Tomoaki ; Garg, Mamta ; Chiu, Christopher ; Wang, Jianping ; Carson, Robin ; Crist, Wendy ; Deraedt, William ; Nguyen, Huong ; Qi, Ming ; San-Miguel, Jesus. / Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. In: New England Journal of Medicine. 2017 ; Vol. 378, No. 6. pp. 518-528.
@article{3acaf3a26f7e43c6af74a627258a67ef,
title = "Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma",
author = "Mar{\'i}a-Victoria Mateos and Dimopoulos, {Meletios A.} and Michele Cavo and Kenshi Suzuki and Andrzej Jakubowiak and Stefan Knop and Chantal Doyen and Paulo Lucio and Zsolt Nagy and Polina Kaplan and Ludek Pour and Mark Cook and Sebastian Grosicki and Andre Crepaldi and Liberati, {Anna M.} and Philip Campbell and Tatiana Shelekhova and Sung-Soo Yoon and Genadi Iosava and Tomoaki Fujisaki and Mamta Garg and Christopher Chiu and Jianping Wang and Robin Carson and Wendy Crist and William Deraedt and Huong Nguyen and Ming Qi and Jesus San-Miguel",
note = "doi: 10.1056/NEJMoa1714678",
year = "2017",
month = "12",
day = "12",
doi = "10.1056/NEJMoa1714678",
language = "English",
volume = "378",
pages = "518--528",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "6",

}

TY - JOUR

T1 - Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma

AU - Mateos, María-Victoria

AU - Dimopoulos, Meletios A.

AU - Cavo, Michele

AU - Suzuki, Kenshi

AU - Jakubowiak, Andrzej

AU - Knop, Stefan

AU - Doyen, Chantal

AU - Lucio, Paulo

AU - Nagy, Zsolt

AU - Kaplan, Polina

AU - Pour, Ludek

AU - Cook, Mark

AU - Grosicki, Sebastian

AU - Crepaldi, Andre

AU - Liberati, Anna M.

AU - Campbell, Philip

AU - Shelekhova, Tatiana

AU - Yoon, Sung-Soo

AU - Iosava, Genadi

AU - Fujisaki, Tomoaki

AU - Garg, Mamta

AU - Chiu, Christopher

AU - Wang, Jianping

AU - Carson, Robin

AU - Crist, Wendy

AU - Deraedt, William

AU - Nguyen, Huong

AU - Qi, Ming

AU - San-Miguel, Jesus

N1 - doi: 10.1056/NEJMoa1714678

PY - 2017/12/12

Y1 - 2017/12/12

U2 - 10.1056/NEJMoa1714678

DO - 10.1056/NEJMoa1714678

M3 - Article

VL - 378

SP - 518

EP - 528

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 6

ER -